Guangzhou’s aviation industry shines at international investment conference
[2018-March-30]
On March 28th, a round table meeting on aviation industry was held as part of the 2018 Guangzhou Annual Investment Conference, aiming to introduce the Guangzhou Aerotropolis Development District and highlight emerging opportunities for global enterprises and investors.
Highlights of the 2018 Guangzhou Anual Investment Conference
[2018-March-30]
Highlights of the 2018 Guangzhou Anual Investment Conference
GPHL holds pharmaceutical & healthcare forum, highlighting new opportunities
[2018-March-30]
On March 28th, a sub-forum on the pharmaceutical and healthcare industry was held as part of the 2018 Guangzhou Annual Investment Conference, aiming to outline the latest progress and emerging opportunities in the industry.
Night of Guangzhou presents charm of local culture to 2018 GAIC guests
[2018-March-30]
The ongoing 2018 Guangzhou Annual Investment Conference (GAIC) is more than economy and entrepreneurship. Yesterday (March 27th), the Conference held the Night of Guangzhou, embracing Guangzhou's local folk brands, like traditional Lingnan music performance and special cuisine of Guangzhou.
Guangzhou holds annual investment conference to lure global investors
[2018-March-30]
The 2018 Guangzhou Annual Investment Conference (GAIC) keeps rolling on March 28, with 2500 guests from over 1800 enterprises around the world.
Nansha appeals to global AI companies
[2018-March-30]
Yesterday on March 28th, the Management Committee of Nansha Free Trade Zone (FTZ) held an AI themed sub-forum at the 2018 Guangzhou Annual Investment Conference, aiming to highlight the district’s opportunities and achievements in building itself as an AI industrial cluster.
An ‘Orange Book’ for TCM proposed at the China Development Forum
[2018-March-30]
A roundtable titled ‘Drug Evaluation and Approval System Reform in the New Era’ was held at the Diaoyutai State Guesthouse in Beijing on the afternoon of March 24 during the 19th China Development Forum (CDF). Representatives of the world’s major producers of pharmaceuticals attended the meeting to share their views on the reform of drug evaluation and approval systems.